Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07750925Not yet recruiting
Open-label, single-arm trial of lithium carbonate in bipolar disorder (BD), sponsored by Northumbria University. Primary endpoints: Plasma melatonin change in response to light stimulation and Brain lithium signal intensity measured by 7Li-MRI at Day 21. Planned start Aug 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07750925.